Alps Advisors Inc Athersys, Inc Transaction History

Alps Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$1.16 - $1.42 $353,167 - $432,326	-304,455 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$1.21 - $1.65 $10,926 - $14,899	-9,030 Reduced 2.88%	304,455 $405,000
Q2 2019 Aug 07, 2019	SELL	$1.39 - $2.03 $40,150 - $58,636	-28,885 Reduced 8.44%	313,485 $527,000
Q1 2019 May 01, 2019	BUY	$1.39 - $1.71 $20,556 - $25,289	14,789 Added 4.51%	342,370 $514,000
Q4 2018 Feb 04, 2019	BUY	$1.41 - $2.16 $116,100 - $177,856	82,341 Added 33.58%	327,581 $472,000
Q3 2018 Oct 25, 2018	BUY	$1.86 - $2.18 $83,744 - $98,152	45,024 Added 22.49%	245,240 $515,000
Q2 2018 Aug 02, 2018	BUY	$1.76 - $2.79 $352,380 - $558,602	200,216 New	200,216 $394,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.